SyntheX

SyntheX uses synthetic lethality to create peptide therapeutics to treat incurable cancers. They have developed an evolutionary platform which can test 10 billion protein variants in one petri dish to evolve new therapeutics.

Be Part of the Revolution!

Next program starts Winter 2017. Early applications due July 30th!